chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Headache, Pain in extremity, Vaccination site erythema
Clinical narrative: chest pain; General fatigue; Itchy at the injection site; Redness on the injection site; "area felt warm"; Severe pain in arm; Slight head ache; general fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), VACCINATION SITE WARMTH ("area felt warm"), PAIN IN EXTREMITY (Severe pain in arm), HEADACHE (Slight head ache) and FATIGUE (general fatigue) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma, Hyperthyroidism and Birth control.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (Severe pain in arm), HEADACHE (Slight head ache) and FATIGUE (general fatigue). On 25-Apr-2021, the patient experienced VACCINATION SITE WARMTH ("area felt warm"), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE ERYTHEMA (Redness on the injection site). On 26-Apr-2021, the patient experienced CHEST PAIN (chest pain) and FATIGUE (General fatigue). At the time of the report, CHEST PAIN (chest pain), VACCINATION SITE WARMTH ("area felt warm"), PAIN IN EXTREMITY (Severe pain in arm), HEADACHE (Slight head ache), FATIGUE (general fatigue), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Redness on the injection site) and FATIGUE (General fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment Ibuprofen
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: chest pain; General fatigue; Itchy at the injection site; Redness on the injection site; "area felt warm"; Severe pain in arm; Slight head ache; general fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), VACCINATION SITE WARMTH ("area felt warm"), PAIN IN EXTREMITY (Severe pain in arm), HEADACHE (Slight head ache) and FATIGUE (general fatigue) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma, Hyperthyroidism and Birth control.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (Severe pain in arm), HEADACHE (Slight head ache) and FATIGUE (general fatigue). On 25-Apr-2021, the patient experienced VACCINATION SITE WARMTH ("area felt warm"), VACCINATION SITE PRURITUS (Itchy at the injection site) and VACCINATION SITE ERYTHEMA (Redness on the injection site). On 26-Apr-2021, the patient experienced CHEST PAIN (chest pain) and FATIGUE (General fatigue). At the time of the report, CHEST PAIN (chest pain), VACCINATION SITE WARMTH ("area felt warm"), PAIN IN EXTREMITY (Severe pain in arm), HEADACHE (Slight head ache), FATIGUE (general fatigue), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Redness on the injection site) and FATIGUE (General fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment Ibuprofen
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Rash
Clinical narrative: sore arm; Rash and redness; Rash and redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), RASH (Rash and redness) and ERYTHEMA (Rash and redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), RASH (Rash and redness) and ERYTHEMA (Rash and redness). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (sore arm), RASH (Rash and redness) and ERYTHEMA (Rash and redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported .
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Significant tenderness around the administering of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Significant tenderness around the administering of the Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Significant tenderness around the administering of the Moderna vaccine). At the time of the report, INJECTION SITE PAIN (Significant tenderness around the administering of the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details not reported by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: overdue for second dose; 50+days; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (overdue for second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50+days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (overdue for second dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (50+days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (overdue for second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.   Caller was unable to provide any adverse effect details . Caller was a healthcare provider and had a patient who was overdue for their second vaccine dose. Caller wants to know what they should do   This case was linked to US-MODERNATX, INC.-MOD-2021-090650 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090650:cluster case for some contractors
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia, Tremor
Clinical narrative: shakes and tremors that are getting worse by the day; fever; felt okay not great; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt okay not great), TREMOR (shakes and tremors that are getting worse by the day) and PYREXIA (fever) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 007B21A) for COVID-19 vaccination.     The patient's past medical history included MS (Had inflammation but it got better after a few months) in 2004. Concurrent medical conditions included Gluten sensitivity, Sulfonamide allergy, Protein allergy and Depression. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for Depression.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FEELING ABNORMAL (felt okay not great). On 24-Apr-2021, the patient experienced TREMOR (shakes and tremors that are getting worse by the day). 24-Apr-2021, the patient experienced PYREXIA (fever). The patient was treated with CLONAZEPAM at a dose of 0.25 mg. At the time of the report, FEELING ABNORMAL (felt okay not great), TREMOR (shakes and tremors that are getting worse by the day) and PYREXIA (fever) had resolved.            Treatment medication included CBD with THC3% and trying to eat but nothing is helping.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Additional document received and contains no new information On 20-Jul-2021: Patient demographics were added.Allergies includes Sulpha,Gluten,Caesin were added.Medical condition includes MS was added.Dose 1 information was provided.Concomitant products include Welbutrin was added.Events outcome was updated from unknown to recovered.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and FATIGUE (Fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 030L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: PREVNAR 13 (Allergy to Prevnar 13 causes swelling and rash). Concurrent medical conditions included Hypertension since 04-Sep-1998, Drug allergy (Lisinopril causes swelling), Shellfish allergy (Shellfish causes swelling) since 27-Jul-2017, Drug allergy (Amlodipine causes hives), Drug allergy (Polyethylene glycol causes hives, itching and swelling), Sulfonamide allergy (Sulfonamide antibiotics causes hives), Drug allergy (Augmentin causes hives), Drug allergy (Azithromycin causes hives), Drug allergy (Brimonidine Combigan  causes hives), Seafood allergy (Shrimp causes swelling), Food allergy (Oats causes hives), Drug allergy (Clindamycin causes facial rash), Drug allergy (Doxycycline causes hives and rash) and Drug allergy (Omnipaque Rediflo 240 causes oral contrast). Concomitant products included ATENOLOL, PRAVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN 81), CALCIUM CARBONATE, COLECALCIFEROL (CALCIUM D3), LATANOPROST from 10-Sep-2020 to an unknown date, EPINEPHRINE (EPIPEN 2-PAK) and CETIRIZINE for an unknown indication.   On 25-Jan-2021 at 4:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021 at 4:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.            No treatment medications were reported.   This case was linked to MOD-2021-029326 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up information received on 28-May-2021 contains Non-significant information.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Vaccination site pain
Clinical narrative: felt fainty; sweaty; Burning where i was injected; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt fainty), HYPERHIDROSIS (sweaty) and VACCINATION SITE PAIN (Burning where i was injected) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (felt fainty), HYPERHIDROSIS (sweaty) and VACCINATION SITE PAIN (Burning where i was injected). At the time of the report, DIZZINESS (felt fainty), HYPERHIDROSIS (sweaty) and VACCINATION SITE PAIN (Burning where i was injected) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.  Company Comment: Very limited information regarding these non serious events has been provided at this time.  Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: report contained no new information; Sender's Comments: Very limited information regarding these non serious events has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Influenza like illness, Pain, Vaccination site pain
Clinical narrative: Pain; Flu like symptoms; Vaccination site tenderness; This spontaneous case was reported by a physician and describes the occurrence of PAIN (Pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Vaccination site tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concomitant products included METHOTREXATE for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage form. On an unknown date, the patient experienced PAIN (Pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Vaccination site tenderness). At the time of the report, PAIN (Pain), INFLUENZA LIKE ILLNESS (Flu like symptoms) and VACCINATION SITE PAIN (Vaccination site tenderness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Lymphadenopathy, Mobility decreased, Neck pain
Clinical narrative: Couldn't turn his neck back because it hurt so bad; Pain continued to get worse, and affected entire side of his body (left side, same side he got his; Pain in his neck; Pain in his back; swelling of lymph nodes in his neck and under his arm; Fatigue; arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting), MOBILITY DECREASED (Couldn't turn his neck back because it hurt so bad), PAIN (Pain continued to get worse, and affected entire side of his body (left side, same side he got his), NECK PAIN (Pain in his neck) and BACK PAIN (Pain in his back) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Thyroiditis and High cholesterol.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting) and FATIGUE (Fatigue). On 01-Apr-2021, the patient experienced MOBILITY DECREASED (Couldn't turn his neck back because it hurt so bad), PAIN (Pain continued to get worse, and affected entire side of his body (left side, same side he got his), NECK PAIN (Pain in his neck), BACK PAIN (Pain in his back) and LYMPHADENOPATHY (swelling of lymph nodes in his neck and under his arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of Two or three. On 02-Apr-2021, PAIN IN EXTREMITY (arm was hurting) and FATIGUE (Fatigue) had resolved. On 03-Apr-2021, MOBILITY DECREASED (Couldn't turn his neck back because it hurt so bad), PAIN (Pain continued to get worse, and affected entire side of his body (left side, same side he got his), NECK PAIN (Pain in his neck) and BACK PAIN (Pain in his back) had resolved. On 04-Apr-2021, LYMPHADENOPATHY (swelling of lymph nodes in his neck and under his arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is on concomitant medicines like Blood pressure medication, Thyroid medication and Cholesterol medication. Advil two or three as treatment medication. Not sure if the patient also took Tylenol.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Couldn't turn his neck back because it hurt so bad; Pain continued to get worse, and affected entire side of his body (left side, same side he got his; Pain in his neck; Pain in his back; swelling of lymph nodes in his neck and under his arm; Fatigue; arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting), MOBILITY DECREASED (Couldn't turn his neck back because it hurt so bad), PAIN (Pain continued to get worse, and affected entire side of his body (left side, same side he got his), NECK PAIN (Pain in his neck) and BACK PAIN (Pain in his back) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high, Thyroiditis and High cholesterol.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting) and FATIGUE (Fatigue). On 01-Apr-2021, the patient experienced MOBILITY DECREASED (Couldn't turn his neck back because it hurt so bad), PAIN (Pain continued to get worse, and affected entire side of his body (left side, same side he got his), NECK PAIN (Pain in his neck), BACK PAIN (Pain in his back) and LYMPHADENOPATHY (swelling of lymph nodes in his neck and under his arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of Two or three. On 02-Apr-2021, PAIN IN EXTREMITY (arm was hurting) and FATIGUE (Fatigue) had resolved. On 03-Apr-2021, MOBILITY DECREASED (Couldn't turn his neck back because it hurt so bad), PAIN (Pain continued to get worse, and affected entire side of his body (left side, same side he got his), NECK PAIN (Pain in his neck) and BACK PAIN (Pain in his back) had resolved. On 04-Apr-2021, LYMPHADENOPATHY (swelling of lymph nodes in his neck and under his arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is on concomitant medicines like Blood pressure medication, Thyroid medication and Cholesterol medication. Advil two or three as treatment medication. Not sure if the patient also took Tylenol.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance
Clinical narrative: could hardly walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (could hardly walk) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported. No concomitant medication was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-1900, the patient experienced GAIT DISTURBANCE (could hardly walk). At the time of the report, GAIT DISTURBANCE (could hardly walk) outcome was unknown. Not Provided   Treatment medication was not provided.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  This case was linked to US-MODERNATX, INC.-MOD-2021-091925 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-091925:Same reporter, different patient
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Fatigue, Feeling cold
Clinical narrative: Shortness of breath after covid; Tired; Fever of 102.6F; Could not sleep; Really freezing; Shivering; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath after covid), INSOMNIA (Could not sleep), FEELING COLD (Really freezing), CHILLS (Shivering) and FATIGUE (Tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 pneumonia (Has been struggling on walks after having COVID due to shortness of breath) in 2020 and Shortness of breath. Concurrent medical conditions included Chronic sinusitis and Lung scarring. Concomitant products included ALBUTEROL [SALBUTAMOL], ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) and ESTRADIOL (ESTROGEN) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INSOMNIA (Could not sleep), FEELING COLD (Really freezing) and CHILLS (Shivering). On 01-Apr-2021, the patient experienced PYREXIA (Fever of 102.6F). On 02-Apr-2021, the patient experienced FATIGUE (Tired). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath after covid). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 2 dosage form. At the time of the report, DYSPNOEA (Shortness of breath after covid), INSOMNIA (Could not sleep), FEELING COLD (Really freezing), CHILLS (Shivering), FATIGUE (Tired) and PYREXIA (Fever of 102.6F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Body temperature: 102.6 (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant products include BP medications.   This case was linked to MOD-2021-098685 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received contains non-significant information. On 29-Jun-2021: Follow-up information received contains non-significant information.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pyrexia
Clinical narrative: Shortness of breath after covid; Tired; Fever of 102.6F; Could not sleep; Really freezing; Shivering; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath after covid), INSOMNIA (Could not sleep), FEELING COLD (Really freezing), CHILLS (Shivering) and FATIGUE (Tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 pneumonia (Has been struggling on walks after having COVID due to shortness of breath) in 2020 and Shortness of breath. Concurrent medical conditions included Chronic sinusitis and Lung scarring. Concomitant products included ALBUTEROL [SALBUTAMOL], ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) and ESTRADIOL (ESTROGEN) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced INSOMNIA (Could not sleep), FEELING COLD (Really freezing) and CHILLS (Shivering). On 01-Apr-2021, the patient experienced PYREXIA (Fever of 102.6F). On 02-Apr-2021, the patient experienced FATIGUE (Tired). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath after covid). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 2 dosage form. At the time of the report, DYSPNOEA (Shortness of breath after covid), INSOMNIA (Could not sleep), FEELING COLD (Really freezing), CHILLS (Shivering), FATIGUE (Tired) and PYREXIA (Fever of 102.6F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Body temperature: 102.6 (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant products include BP medications.   This case was linked to MOD-2021-098685 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received contains non-significant information. On 29-Jun-2021: Follow-up information received contains non-significant information.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: large red spot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (large red spot) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (large red spot). At the time of the report, VACCINATION SITE ERYTHEMA (large red spot) outcome was unknown. Not Provided          Action taken with response to the events are not applicable
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chapped lips, Dizziness, Dyspnoea, Feeling of body temperature change
Clinical narrative: Weakness; Swollen tongue; Lips cracked; Toes were numb; Cold feet; Tingling fingers; sensation of hotness and coldness; Dizziness; shortness of breath; Headache; Sore throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat) and ASTHENIA (Weakness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLONAZEPAM, GABAPENTIN, FAMOTIDINE, PRAVASTATIN, CALCIUM and TOCOPHEROL, UBIDECARENONE, ZINC (COENZYME Q10+) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat), ASTHENIA (Weakness), SWOLLEN TONGUE (Swollen tongue), CHAPPED LIPS (Lips cracked), HYPOAESTHESIA (Toes were numb), PERIPHERAL COLDNESS (Cold feet), PARAESTHESIA (Tingling fingers) and FEELING OF BODY TEMPERATURE CHANGE (sensation of hotness and coldness). At the time of the report, DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat), PERIPHERAL COLDNESS (Cold feet), PARAESTHESIA (Tingling fingers) and FEELING OF BODY TEMPERATURE CHANGE (sensation of hotness and coldness) outcome was unknown. Unknown          The treatment history was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Oropharyngeal pain, Paraesthesia, Peripheral coldness
Clinical narrative: Weakness; Swollen tongue; Lips cracked; Toes were numb; Cold feet; Tingling fingers; sensation of hotness and coldness; Dizziness; shortness of breath; Headache; Sore throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat) and ASTHENIA (Weakness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLONAZEPAM, GABAPENTIN, FAMOTIDINE, PRAVASTATIN, CALCIUM and TOCOPHEROL, UBIDECARENONE, ZINC (COENZYME Q10+) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat), ASTHENIA (Weakness), SWOLLEN TONGUE (Swollen tongue), CHAPPED LIPS (Lips cracked), HYPOAESTHESIA (Toes were numb), PERIPHERAL COLDNESS (Cold feet), PARAESTHESIA (Tingling fingers) and FEELING OF BODY TEMPERATURE CHANGE (sensation of hotness and coldness). At the time of the report, DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat), PERIPHERAL COLDNESS (Cold feet), PARAESTHESIA (Tingling fingers) and FEELING OF BODY TEMPERATURE CHANGE (sensation of hotness and coldness) outcome was unknown. Unknown          The treatment history was not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: Weakness; Swollen tongue; Lips cracked; Toes were numb; Cold feet; Tingling fingers; sensation of hotness and coldness; Dizziness; shortness of breath; Headache; Sore throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat) and ASTHENIA (Weakness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CLONAZEPAM, GABAPENTIN, FAMOTIDINE, PRAVASTATIN, CALCIUM and TOCOPHEROL, UBIDECARENONE, ZINC (COENZYME Q10+) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat), ASTHENIA (Weakness), SWOLLEN TONGUE (Swollen tongue), CHAPPED LIPS (Lips cracked), HYPOAESTHESIA (Toes were numb), PERIPHERAL COLDNESS (Cold feet), PARAESTHESIA (Tingling fingers) and FEELING OF BODY TEMPERATURE CHANGE (sensation of hotness and coldness). At the time of the report, DIZZINESS (Dizziness), DYSPNOEA (shortness of breath), HEADACHE (Headache), OROPHARYNGEAL PAIN (Sore throat), PERIPHERAL COLDNESS (Cold feet), PARAESTHESIA (Tingling fingers) and FEELING OF BODY TEMPERATURE CHANGE (sensation of hotness and coldness) outcome was unknown. Unknown          The treatment history was not provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Vaccination site pain
Clinical narrative: Pain invloves the Left breast; Developed pain under her left arm and invloves the underarm; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Pain invloves the Left breast), AXILLARY PAIN (Developed pain under her left arm and invloves the underarm) and VACCINATION SITE PAIN (Pain at the injection site) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 25-Apr-2021, the patient experienced AXILLARY PAIN (Developed pain under her left arm and invloves the underarm). On 26-Apr-2021, the patient experienced BREAST PAIN (Pain invloves the Left breast). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. On 23-Apr-2021, VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, BREAST PAIN (Pain invloves the Left breast) and AXILLARY PAIN (Developed pain under her left arm and invloves the underarm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Soreness on the left arm\soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness on the left arm\soreness) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced MYALGIA (Soreness on the left arm\soreness). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. On 23-Apr-2021, MYALGIA (Soreness on the left arm\soreness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details were provided. Treatment information provided was Tylenol.  Patient called in stating that he had called in earlier and spoke to 2 other agents regarding his concern. He received a voicemail from Moderna asking about an adverse reaction. Stated he had soreness after his first dose on 21Apr2021 but this went away after a day or two but he has never called Moderna about this.   Pertinent details regarding his vaccination was not gathered as caller insisted that agent look into a possible identity theft.   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow-up received on 29-May-21. Nonserious event added
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: facial swelling on the left side of face; rash on his forehead; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (facial swelling on the left side of face) and RASH (rash on his forehead) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     Concomitant products included EMPAGLIFLOZIN (JARDIANCE), GLIMEPIRIDE, ROSUVASTATIN and LISINOPRIL for Product used for unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 ml. On 23-Apr-2021, the patient experienced SWELLING FACE (facial swelling on the left side of face). 23-Apr-2021, the patient experienced RASH (rash on his forehead). At the time of the report, SWELLING FACE (facial swelling on the left side of face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Herpes zoster, Hypoaesthesia
Clinical narrative: Shingles; pain went from her armpit to her elbow; numbness through the armpit; had difficulty breathing; Lymph nodes were inflamed on the arm; Body aches; Hreadache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing) and LYMPHADENOPATHY (Lymph nodes were inflamed on the arm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing), LYMPHADENOPATHY (Lymph nodes were inflamed on the arm), MYALGIA (Body aches), HEADACHE (Hreadache) and CHILLS (chills). At the time of the report, HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing), LYMPHADENOPATHY (Lymph nodes were inflamed on the arm), MYALGIA (Body aches), HEADACHE (Hreadache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Pain in extremity
Clinical narrative: Shingles; pain went from her armpit to her elbow; numbness through the armpit; had difficulty breathing; Lymph nodes were inflamed on the arm; Body aches; Hreadache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing) and LYMPHADENOPATHY (Lymph nodes were inflamed on the arm) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing), LYMPHADENOPATHY (Lymph nodes were inflamed on the arm), MYALGIA (Body aches), HEADACHE (Hreadache) and CHILLS (chills). At the time of the report, HERPES ZOSTER (Shingles), PAIN IN EXTREMITY (pain went from her armpit to her elbow), HYPOAESTHESIA (numbness through the armpit), DYSPNOEA (had difficulty breathing), LYMPHADENOPATHY (Lymph nodes were inflamed on the arm), MYALGIA (Body aches), HEADACHE (Hreadache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   Reporter did not allow further contact
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchospasm
Clinical narrative: minor bronchial constriction, eoisode which is less than Asthmatic Attack; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHOSPASM (minor bronchial constriction, eoisode which is less than Asthmatic Attack) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included Psoriatic arthritis. Concomitant products included ATORVASTATIN, TEMAZEPAM and BUPROPION HYDROCHLORIDE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BRONCHOSPASM (minor bronchial constriction, eoisode which is less than Asthmatic Attack). At the time of the report, BRONCHOSPASM (minor bronchial constriction, eoisode which is less than Asthmatic Attack) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment details were provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Headache, Pyrexia
Clinical narrative: vision and anxiety; fever; permanent ringing on her head, intense headaches; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (vision and anxiety), HEADACHE (permanent ringing on her head, intense headaches) and PYREXIA (fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031a21a and 008b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced HEADACHE (permanent ringing on her head, intense headaches). On 12-Apr-2021, the patient experienced ANXIETY (vision and anxiety) and PYREXIA (fever). At the time of the report, ANXIETY (vision and anxiety), HEADACHE (permanent ringing on her head, intense headaches) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other Concomitant Medication provided was Cholesterol medication and Gastritis medication. No treatment  was provided.   This case was linked to MOD-2021-092382 (Patient Link).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Injection site scar, Pyrexia, Scar
Clinical narrative: dime sized raised scar mark at injection site of left arm; red scar mark at injection site of left arm; Flu like symptoms; fever; chills; soreness at injection site of left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site of left arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (fever), CHILLS (chills) and SCAR (dime sized raised scar mark at injection site of left arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site of left arm). On 02-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (fever) and CHILLS (chills). On an unknown date, the patient experienced SCAR (dime sized raised scar mark at injection site of left arm) and INJECTION SITE SCAR (red scar mark at injection site of left arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Antidepressant therapy, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness at injection site of left arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (fever), CHILLS (chills), SCAR (dime sized raised scar mark at injection site of left arm) and INJECTION SITE SCAR (red scar mark at injection site of left arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment with Advil medication was provided for first dose events.   This case was linked to US-MODERNATX, INC.-MOD-2021-092455 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092455:2nd Dose events
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: dime sized raised scar mark at injection site of left arm; red scar mark at injection site of left arm; Flu like symptoms; fever; chills; soreness at injection site of left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at injection site of left arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (fever), CHILLS (chills) and SCAR (dime sized raised scar mark at injection site of left arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site of left arm). On 02-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (fever) and CHILLS (chills). On an unknown date, the patient experienced SCAR (dime sized raised scar mark at injection site of left arm) and INJECTION SITE SCAR (red scar mark at injection site of left arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Antidepressant therapy, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (soreness at injection site of left arm), INFLUENZA LIKE ILLNESS (Flu like symptoms), PYREXIA (fever), CHILLS (chills), SCAR (dime sized raised scar mark at injection site of left arm) and INJECTION SITE SCAR (red scar mark at injection site of left arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment with Advil medication was provided for first dose events.   This case was linked to US-MODERNATX, INC.-MOD-2021-092455 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092455:2nd Dose events